157 related articles for article (PubMed ID: 92577)
1. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins.
Strnad BC; Neubauer RH; Rabin H; Mazur RA
J Virol; 1979 Dec; 32(3):885-94. PubMed ID: 92577
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.
Strnad BC; Schuster T; Klein R; Hopkins RF; Witmer T; Neubauer RH; Rabin H
J Virol; 1982 Jan; 41(1):258-64. PubMed ID: 6177865
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
Qualtiere LF; Pearson GR
Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
[TBL] [Abstract][Full Text] [Related]
4. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
5. Polypeptides of the Epstein-Barr virus membrane antigen complex.
Thorley-Lawson DA; Edson CM
J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
[TBL] [Abstract][Full Text] [Related]
6. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
Qualtiere LF; Pearson GR
Virology; 1980 Apr; 102(2):360-9. PubMed ID: 6245514
[No Abstract] [Full Text] [Related]
7. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
8. Quantification of an Epstein-Barr virus-associated membrane antigen component.
North JR; Morgan AJ; Thompson JL; Epstein MA
J Virol Methods; 1982 Sep; 5(1):55-65. PubMed ID: 6292251
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.
Kallin B; Luka J; Klein G
J Virol; 1979 Dec; 32(3):710-6. PubMed ID: 229261
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies.
Yokochi T; Clark EA; Kimura Y
Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025
[TBL] [Abstract][Full Text] [Related]
12. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
Franklin SM; North JR; Morgan AJ; Epstein MA
J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
[TBL] [Abstract][Full Text] [Related]
13. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
Lin JC; Choi EI; Pagano JS
J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
Mueller-Lantzsch N; Yamamoto N
J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
[TBL] [Abstract][Full Text] [Related]
17. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
Hinuma Y; Sakamoto K
IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
[TBL] [Abstract][Full Text] [Related]
18. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
Casareale D; Jones W; Sairenji T; Humphreys RE
Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
[TBL] [Abstract][Full Text] [Related]
19. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants.
Dölken G; Klein G
J Natl Cancer Inst; 1977 May; 58(5):1239-45. PubMed ID: 192896
[TBL] [Abstract][Full Text] [Related]
20. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]